BB BIOTECH AG 13D and 13G filings for ESSA Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:32 pm Sale |
2024-11-01 | 13G | ESSA Pharma Inc. EPIX |
BB BIOTECH AG | 0 0.000% |
-7,879,583 (Position Closed) |
Filing |
| 2024-02-13 06:04 am Unchanged |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
BB BIOTECH AG | 7,879,583 17.900% |
0 (Unchanged) |
Filing |
| 2023-02-14 4:12 pm Purchase |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
BB BIOTECH AG | 7,879,583 17.900% |
2,863,769 (+57.09%) |
Filing |
| 2022-02-11 4:46 pm Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
BB BIOTECH AG | 5,015,814 11.400% |
250,000 (+5.25%) |
Filing |
| 2021-08-17 1:57 pm Purchase |
2021-08-16 | 13G | ESSA Pharma Inc. EPIX |
BB BIOTECH AG | 4,765,814 10.800% |
2,780,000 (+139.99%) |
Filing |
| 2021-05-05 5:20 pm Purchase |
2021-04-29 | 13G | ESSA Pharma Inc. EPIX |
BB BIOTECH AG | 1,985,814 5.100% |
1,985,814 (New Position) |
Filing |